Yazhou Yao

机构：Baoji City Central Hospital

发表论文 18 篇 · 总被引 304 次 · h-index 7

代表论文

VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients (2018 · CHEST Journal · 被引 103)
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia (2021 · Journal of Hematology & Oncology · 被引 73)
Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells (2014 · Tumor Biology · 被引 46)
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial) (2022 · Blood Cancer Journal · 被引 41)
Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study (2021 · Journal of Thrombosis and Haemostasis · 被引 14)
Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens (2023 · Journal of Medical Virology · 被引 8)